Global Female Technology (Femtech) Market

2.1    Key Questions Answered in the Report

3.1    Primary Data Sources
3.2    Secondary Data Sources
3.3    Market Estimation Model
3.4    Companies Profiled
3.5    Assumptions and Limitations

4.1    Industry Trends
         4.1.1    Increased Use of Personalized Apps for Menstrual Tracking
         4.1.2    Pricing and Branding Strategies
         4.1.3    Femtech in Emerging Economies
         4.1.4    Growing Emphasis on Holistic Women Healthcare
         4.1.5    Smart Medical Devices and Wearables
         4.1.6    Destigmatizing Menstrual Health and Menopause
4.2    Femtech Innovation Tracker
         4.2.1    Wearable Devices for Fertility Tracking
         4.2.2    Vaginal Sensor for Fertility Cycle Monitoring
         4.2.3    Leveraging Genomics and Big Data for Fertility Tracking and Menstrual Health
         4.2.4    Wearables for Breast Cancer Screening
4.3    Regulatory Framework
         4.3.1    Regulatory Framework in North America
                     4.3.1.1    Connected Devices
                     4.3.1.2    Mobile Medical Apps (MMAs)
                     4.3.1.3    Software-as-a-Medical-Device (SaMD)
                     4.3.1.4    General Considerations for SaMDs
         4.3.2    Regulatory Framework in Europe
                     4.3.2.1    Medical Device Software (MDSW)
                     4.3.2.2    Artificial Intelligence
4.4    Funding Analysis
         4.4.1    Femtech Received Funding Worth more than $1 Billion Over the Last 5 Years
         4.4.2    Notable Private Funding in Femtech

5.1    Key Developments and Strategies
         5.1.1    Funding
         5.1.2    Collaborations and Partnerships
         5.1.3    Product Launch and Upgradation
         5.1.4    Mergers and Acquisitions
5.2    Business Model Analysis
         5.2.1    One-for-One Give Back Model
         5.2.2    Direct-to-Consumer
         5.2.3    Subscription
         5.2.4    Prescription Telemedicine Model
5.3    Product Mapping Analysis

6.1    Market Drivers
         6.1.1    Increased Interest from Venture Capitalists in Femtech
         6.1.2    Economic Burden by Women’s Health is More Than $500 Billion
         6.1.3    Explosion of Wearable Devices and Increasing Smartphone Penetration Among Women
6.2    Market Restraints
         6.2.1    Societal Taboos Surrounding Women’s Health Issues
         6.2.2    Absence of Awareness Among Women in Rural Areas
         6.2.3    Lack of Scientific Studies to Back Industrial Claims
         6.2.4    Challenges Related to Product Marketing in Femtech Space
6.3    Market Opportunities
         6.3.1    Investment in Product Development for Maternal, Pre- and Neo-Natal Care
         6.3.2    Investment in Sub-Saharan Africa
         6.3.3    Product Development for Menopause Management

7.1    Assumptions and Limitations
7.2    Key Findings and Opportunity Assessment
         7.2.1    Key Findings
                     7.2.1.1    Tech-Enabled Solutions for Fertility
                     7.2.1.2    Femtech for Pregnancy Postpartum
                                    7.2.1.2.1    Telehealth
                                    7.2.1.2.2    Remote Patient Monitoring (RPM) with Smart Connected Devices
         7.2.2    Opportunity Assessment

8.1    Overview
8.2    Mobile Apps
8.3    Connected Devices
         8.3.1    Wearable Connected Device
         8.3.2    Non-Wearable Connected Device
8.4    Services
8.5    Others (Organic, Smart Female Hygiene Products)

9.1    Overview
9.2    Reproductive Health
         9.2.1    Period Tracking
         9.2.2    At-Home Fertility Tracking and Monitoring
9.3    General Wellness
         9.3.1    Menopause
9.4    Pregnancy and Nursing Care
         9.4.1    Pregnancy Care
         9.4.2    Post Pregnancy Care
                     9.4.2.1    Post-Partum Depression
         9.4.3    Breastfeeding
9.5    Pelvic and Uterine Care
         9.5.1    Pelvic Wellness
         9.5.2    Menstrual Health

10.1    Overview
10.2    Individuals
10.3    Fertility Clinics
10.4    Hospitals and Research Institutes
10.5    Diagnostic Centers

11.1    Overview
11.2    North America
           11.2.1    U.S.
           11.2.2    Canada
11.3    Europe
           11.3.1    Germany
           11.3.2    U.K.
           11.3.3    Sweden
           11.3.4    Spain
           11.3.5    France
           11.3.6    Netherlands
           11.3.7    Rest-of-Europe
11.4    Asia-Pacific
           11.4.1    China
           11.4.2    Japan
           11.4.3    South Korea
           11.4.4    Australia
           11.4.5    India
           11.4.6    Rest-of-Asia-Pacific
11.5    Rest-of-the-World
           11.5.1    Middle East
                         11.5.1.1    Israel
                         11.5.1.2    Saudi Arabia
                         11.5.1.3    U.A.E.
           11.5.2    South Africa
           11.5.3    Latin America
                         11.5.3.1    Brazil
                         11.5.3.2    Mexico
           11.5.4    Rest-of-the-Countries

12.1    Overview
12.2    ALYK, Inc.
           12.2.1    Company Overview
           12.2.2    Role of ALYK, Inc. in the Global Femtech Market
           12.2.3    Recent Developments
           12.2.4    SWOT Analysis: ALYK, Inc.
12.3    Aytu BioScience, Inc.
           12.3.1    Company Overview
           12.3.2    Role of Aytu Bioscience, Inc. in the Global Femtech Market
           12.3.3    Financials
           12.3.4    Recent Developments
           12.3.5    SWOT Analysis
12.4    Biowink GmbH
           12.4.1    Company Overview
           12.4.2    Role of Biowink GmbH in the Global Femtech Market
           12.4.3    Recent Developments
           12.4.4    SWOT Analysis: Biowink GmbH
12.5    Bloomlife
           12.5.1    Company Overview
           12.5.2    Role of Bloomlife GmbH in the Global Femtech Market
           12.5.3    Recent Developments
           12.5.4    SWOT Analysis: Bloomlife
12.6    CORA
           12.6.1    Company Overview
           12.6.2    Role of CORA in the Global Femtech Market
           12.6.3    Recent Developments
           12.6.4    SWOT Analysis: CORA
12.7    Flo Health, Inc.
           12.7.1    Company Overview
           12.7.2    Role of Flo Health Inc. in the Global Femtech Market
           12.7.3    Recent Developments
           12.7.4    SWOT Analysis: Flo Health Inc.
12.8    Glow, Inc.
           12.8.1    Company Overview
           12.8.2    Role of Glow, Inc. in the Global Femtech Market
           12.8.3    Recent Developments
           12.8.4    SWOT Analysis: Glow, Inc.
12.9    Inne
           12.9.1    Company Overview
           12.9.2    Role of Inne in the Global Femtech Market
           12.9.3    Recent Developments
           12.9.4    SWOT Analysis: Inne.
12.10    Kasha
             12.10.1    Company Overview
             12.10.2    Role of Kasha in the Global Femtech Market
             12.10.3    Recent Developments
             12.10.4    SWOT Analysis: Kasha
12.11    NaturalCycles Nordic AB
             12.11.1    Company Overview
             12.11.2    Role of NaturalCycles Nordic AB in the Global Femtech Market
             12.11.3    Recent Developments
             12.11.4    SWOT Analysis: NaturalCycles Nordic AB
12.12    Ovia Health
             12.12.1    Company Overview
             12.12.2    Role of Ovia Health Inc. in the Global Femtech Market
             12.12.3    Recent Developments
             12.12.4    SWOT Analysis: Ovia Health
12.13    Plackal Tech
             12.13.1    Company Overview
             12.13.2    Role of Plackal Tech in the Global Femtech Market
             12.13.3    Recent Developments
             12.13.4    SWOT Analysis: Plackal Tech.
12.14    Sustain Natural
             12.14.1    Company Overview
             12.14.2    Role of Sustain Natural in the Global Femtech Market
             12.14.3    Recent Developments
             12.14.4    SWOT Analysis: Sustain Natural
12.15    The Flex Company
             12.15.1    Company Overview
             12.15.2    Role of The Flex Company in the Global Femtech Market
             12.15.3    Recent Developments
             12.15.4    SWOT Analysis: The Flex Company
12.16    Thinx Inc.
             12.16.1    Company Overview
             12.16.2    Role of Thinx Inc. in the Global Femtech Market
             12.16.3    Recent Developments
             12.16.4    SWOT Analysis: Thinx Inc.
12.17    Company Snapshots
             12.17.1    Celmatix Inc.
                             12.17.1.1    Company Overview
                             12.17.1.2    Role of Celmatix Inc. in the Global Femtech Market
             12.17.2    Conceivable Inc.
                             12.17.2.1    Company Overview
                             12.17.2.2    Role of Conceivable Inc. in the Global Femtech Market
             12.17.3    Lia Diagnostics Inc.
                             12.17.3.1    Company Overview
                             12.17.3.2    Role of Lia Diagnostics Inc. in the Global Femtech Market
             12.17.4    Lucina Health, Inc. (Subsidiary of Unified Women’s Healthcare, LLC)
                             12.17.4.1    Company Overview
                             12.17.4.2    Role of Lucina Health, Inc. in the Global Femtech Market
             12.17.5    Progyny, Inc.
                             12.17.5.1    Company Overview
                             12.17.5.2    Role of Progyny, Inc. in the Global Femtech Market
             12.17.6    Univfy Inc.
                             12.17.6.1    Company Overview
                             12.17.6.2    Role of Univfy Inc. in the Global Femtech Market

Table 4.1:    Key Femtech Apps for Menstrual Tracking
Table 4.2:    Pricing and Branding Strategy in the Global Femtech Market
Table 4.3:    Celmatix, Inc: Product Portfolio
Table 4.4:    IMDRF Classification: SaMD Categories
Table 4.5:    General Considerations for SaMDs
Table 4.6:    Challenges Faced in MDR Implementation
Table 4.7:    IMDRF Risk Classification: MDR
Table 4.8:    Venture Capital Firms for Women Health
Table 4.9:    Private Funding in Global Femtech Market, 2019
Table 5.1:    Global Femtech Market, Products
Table 6.1:    Prevalence of Diseases in Women, 2017
Table 6.2:    Global Mobile Phone Adoption by Women
Table 7.1:    Few Apps Dedicated to Postpartum Depression
Table 8.1:    Mobile Applications for Women Reproductive Health
Table 8.2:    Femtech Integration in Fertility Treatment
Table 9.1:    Competitive Analysis
Table 9.2:    Leading Products Related to General Wellness
Table 9.3:    Healthcare Burden of Conditions Attributed to Menopause (2017)
Table 9.4:    Wearables for Pregnancy Care
Table 9.5:    Leading Solutions Developed by Healthcare Organizations for Gestational Diabetes Mellitus (GDM) Monitoring
Table 9.6:    Salient Features of Freely Available Mobile Apps that Help Women to Ease into Postpartum
Table 10.1:    Privacy Policy Analysis
Table 11.1:    Breakdown of Funding Under National Women’s Health Strategy 2020-2030
Table 11.2:    Other Innovative Femtech Start-Ups in Israel

Figure 1:    Evolutionary Phases in Global Femtech Market
Figure 2:    Global Femtech Market: Potential Growth Scenarios
Figure 3:    Emerging Technologies and Trends in the Global Femtech Landscape
Figure 4:    Gender Gaps in Mobile Internet Use (by Region), 2017-2019
Figure 5:    Global Femtech Market Drivers and Restraints: Impact Analysis
Figure 6:    Global Femtech Market Growth Share Matrix (by Region), 2019-2030
Figure 7:    Global Femtech Market Growth (by Region), 2018-2030
Figure 8:    Global Femtech Market Growth (by End User)
Figure 2.1:    Global Femtech Market Segmentation
Figure 3.1:    Global Femtech Market Methodology
Figure 3.2:    Primary Research Methodology
Figure 3.3:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4:    Top-Down Approach (Segment-Wise Analysis)
Figure 4.1:    AI/ML Workflow: TPLC Approach Proposed by FDA
Figure 4.2:    Venture Capital Firms Deal Count, 2008-2018
Figure 5.1:    Share of Key Developments and Strategies, January 2016-March 2020
Figure 5.2:    Funding Activity Share (by Company), January 2016-March 2020
Figure 5.3:    Collaborations and Partnerships Share (by Company), January 2016-March 2020
Figure 5.4:    Product Launches (by Company), January 2016-March 2020
Figure 5.5:    Mergers and Acquisitions (by Company), January 2016- March 2020
Figure 5.6:    Global Femtech Market, Product Mapping Analysis, 2019
Figure 6.1:    Women Health Expenditure in the U.S., $Million, 2016-2020
Figure 6.2:    Global Wearable Device Adoption by Women, 2018
Figure 6.3:    Key Barriers to Mobile Ownership for Women (by Region), 2019
Figure 7.1:    Key Trends Influencing Fertility Services in the Femtech Market
Figure 7.2:    Percentage of Maternal Deaths Before, During, and After Delivery, in the U.S.
Figure 7.3:    Global Telehealth Market Share (by Region), 2019, 2025, and 2030
Figure 8.1:    Global Femtech Market (by Component)
Figure 8.2:    Global Femtech Market (Apps), 2018-2030
Figure 8.3:    Workflow in a Period Tracking Application
Figure 8.4:    Global Femtech Market (Connected Devices), $Million, 2018-2030
Figure 8.5:    Global Femtech Market (Services), $Million, 2018-2030
Figure 8.6:    Global Femtech Market (Others), $Million, 2018-2030
Figure 9.1:    Global Femtech Market (by Application)
Figure 9.2:    Global Femtech Market (Reproductive Health), $Million, 2018-2030
Figure 9.3:    Global Femtech Market (General Wellness), $Million, 2018-2030
Figure 9.4:    Global Femtech Market (Pregnancy and Nursing Care), $Million, 2018-2030
Figure 9.5:    Global Femtech Market (Pelvic and Uterine Care), $Million, 2018-2030
Figure 10.1:    Global Femtech Market (Individual Users), $Million, 2018-2030
Figure 10.2:    Global Femtech Market (Fertility Clinics), $Million, 2018-2030
Figure 10.3:    Global Femtech Market (Hospitals and Research Institutes), $Million, 2018-2030
Figure 10.4:    Global Femtech Market (Diagnostic Centers), $Million,2018-2030
Figure 11.1:    Global Femtech Market (by Region), 2019
Figure 11.2:    North America Femtech Market, $Million, 2018-2030
Figure 11.3:    North America: Market Dynamics
Figure 11.4:    U.S. Femtech Market, $Million, 2018-2030
Figure 11.5:    Canada Femtech Market, $Million, 2018-2030
Figure 11.6:    Europe Femtech Market, $Million, 2018-2030
Figure 11.7:    Europe: Market Dynamics
Figure 11.8:    Germany Femtech Market, $Million, 2018-2030
Figure 11.9:    U.K. Femtech Market, $Million, 2018-2030
Figure 11.10:    Sweden Femtech Market, $Million, 2018-2030
Figure 11.11:    Spain Femtech Market, $Million, 2018-2030
Figure 11.12:    France Femtech Market, $Million, 2018-2030
Figure 11.13:    Netherlands Femtech Market, $Million, 2018-2030
Figure 11.14:    Rest-of-Europe Femtech Market, $Million, 2018-2030
Figure 11.15:    Asia-Pacific Femtech Market, $Million, 2018-2030
Figure 11.16:    Asia-Pacific: Market Dynamics
Figure 11.17:    China Femtech Market, $Million, 2018-2030
Figure 11.18:    Fertility Levels in China, 1960-2019
Figure 11.19:    Japan Femtech Market, $Million, 2018-2030
Figure 11.20:    South Korea Femtech Market, $Million, 2018-2030
Figure 11.21:    Australia Femtech Market, $Million, 2018-2030
Figure 11.22:    India Femtech Market, $Million, 2018-2030
Figure 11.23:    Rest-of-Asia-Pacific Femtech Market, $Million, 2018-2030
Figure 11.24:    Rest-of-the-World Femtech Market, $Million, 2018-2030
Figure 11.25:    Middle East, Africa, and Latin America: Market Dynamics
Figure 11.26:    Israel Femtech Market, $Million, 2018-2030
Figure 11.27:    Saudi Arabia Femtech Market, $Million, 2018-2030
Figure 11.28:    U.A.E. Femtech Market, $Million, 2018-2030
Figure 11.29:    South Africa Femtech Market, $Million, 2018-2030
Figure 11.30:    Brazil Femtech Market, $Million, 2018-2030
Figure 11.31:    Mexico Femtech Market, $Million, 2018-2030
Figure 11.32:    Rest-of-the-Countries Femtech Market, $Million, 2018-2030
Figure 12.1:    ALYK, Inc.: Product Portfolio for the Global Femtech Market
Figure 12.2:    ALYK, Inc.: SWOT Analysis
Figure 12.3:    Aytu Bioscience, Inc.: Product Portfolio for Global Femtech Market
Figure 12.4:    Aytu Bioscience: Overall Financials, 2017-2019
Figure 12.5:    Aytu Bioscience, Inc. Revenue (by Region), 2018-2019
Figure 12.6:    Aytu Bioscience, Inc. R&D Expenditure, 2017-2019
Figure 12.7:    Aytu Bioscience, Inc: SWOT Analysis
Figure 12.8:    Biowink GmbH: Product Portfolio for the Global Femtech Market
Figure 12.9:    Biowink GmbH.: SWOT Analysis
Figure 12.10:    Bloomlife: Product Portfolio for the Global Femtech Market
Figure 12.11:    Bloomlife.: SWOT Analysis
Figure 12.12:    CORA.: Product Portfolio for the Global Femtech Market
Figure 12.13:    CORA SWOT Analysis
Figure 12.14:    Flo Health Inc.: Product Portfolio for the Global Femtech Market
Figure 12.15:    Flo Health Inc.: SWOT Analysis
Figure 12.16:    Glow, Inc.: Product Portfolio for the Global Femtech Market
Figure 12.17:    Glow, Inc.: SWOT Analysis
Figure 12.18:    Inne.: Product Portfolio for the Global Femtech Market
Figure 12.19:    Inne. SWOT Analysis
Figure 12.20:    Kasha.: Product Portfolio for the Global Femtech Market
Figure 12.21:    Kasha SWOT Analysis
Figure 12.22:    NaturalCycles Nordic AB.: Product Portfolio for the Global Femtech Market
Figure 12.23:    NaturalCycles Nordic AB: SWOT Analysis
Figure 12.24:    Ovia Health.: Product Portfolio for the Global Femtech Market
Figure 12.25:    Ovia Health: SWOT Analysis
Figure 12.26:    Plackal Tech: Product Portfolio for the Global Femtech Market
Figure 12.27:    Plackal Tech.: SWOT Analysis
Figure 12.28:    Sustain Natural.: Product Portfolio for the Global Femtech Market
Figure 12.29:    Sustain Natural SWOT Analysis
Figure 12.30:    The Flex Company: Product Portfolio for the Global Femtech Market
Figure 12.31:    The Flex Company SWOT Analysis
Figure 12.32:    Thinx Inc.: Product Portfolio for the Global Femtech Market
Figure 12.33:    Thinx Inc. SWOT Analysis